Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin

This publication has 8 references indexed in Scilit:

• Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats
  British Journal of Pharmacology, 1990
• Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats
  Journal of Pharmacy and Pharmacology, 1989
• 5-HT1A AND ALPHA-2 ADRENERGIC-RECEPTORS MEDIATE THE HYPERGLYCEMIC AND HYPOINSULINEMIC EFFECTS OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN IN THE CONSCIOUS RAT
  1987
• Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats
  European Journal of Pharmacology, 1987
• Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological Analysis
  Journal of Cardiovascular Pharmacology, 1987
• Pentobarbital anesthesia suppresses basal and 2-deoxy-D-glucose-stimulated plasma catecholamines
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1984
• Effects of 2-Deoxy-D-Glucose on the Cardiac Sympathetic Nerves and the Adrenal Medulla in the Rat: Further Evidence for a Dissociation of Sympathetic Nervous System and Adrenal Medullary Responses*
  Endocrinology, 1982
• On the mechanism of barbiturate anaesthesia
  The Journal of Physiology, 1972